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Background: The importance of oral health care in the management of patients with systemic diseases including
chronic kidney disease (CKD) has been affirmed. Many CKD patients have related oral lesions, however, attention to
oral health care has been lacking, especially in the developing countries with higher burden of renal diseases.
Methods: One hundred and eighty patients, 90 cases and 90 controls were recruited, interviewed and examined.
Oral mucosa assessment was based on the WHO Guide to Epidemiology and Diagnosis of Oral Mucosal Diseases.
Urinalysis and blood creatinine levels were determined. Glomerular filtration rate (GFR) of each patient was
calculated from the blood creatinine using Cockcroft and Gault formula.
Results: Oral lesions were present in 86 out of 90 (96.5%) CKD patients compared with 15 out of 90 (16.7%)
controls (p < 0.001). Abnormal lip hyperpigmentation was the most frequently seen lesion in 81 out of 90 (90%)
CKD patients. Other significant findings were gum bleeding, xerostomia, candidiasis, burning mouth and abnormal
taste. In the controls (without CKD), the mean GFR was lower in subjects with oral lesions compared with those
without oral lesions p < 0.001.
Conclusions: CKD and reduced GFR in subjects without CKD are risk factors for oral lesions. The higher prevalence of
oral lesions in CKD patients necessitates mandatory oral screening to identify patients with deteriorating renal function.
The management of such lesions will enhance the overall well-being of CKD patients in developing countries.
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The mouth is a powerful diagnostic tool in the clinical
assessment of systemic health [1]. Peculiar oral findings
have been reported in diseases such as Human Im-
munodeficiency Virus (HIV) infection where unusual
oral lesions have aided the diagnosis of HIV infection
among routine dental patients [2]. Other diseases where
oral manifestations may play a vital role in the diagno-
sis and management include diabetes mellitus [3], cor-
onary heart disease [4], graft versus host disease [5] and
chronic kidney disease [6].
Generally, the reported oral lesions in systemic ill-
ness include periodontitis, white patches, red patches,* Correspondence: Phemyhoye12@yahoo.com
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unless otherwise stated.mucositis, oral candidiasis, burning sensation, changes
in salivary composition and flow rates, pale mucosa
and abnormal pigmentation [6,7]. The presence of
these specific oral lesions is not only helpful in detect-
ing underlying systemic diseases but may also indicate
the severity of such systemic diseases [8]. In addition,
significant improvement in systemic health has been
reported following the treatment of associated oral le-
sions [6,8].
Chronic kidney disease (CKD) like many other sys-
temic diseases, have associated oral problems arising
from the disease process or the effects of therapy or
both. Consequently, untreated oral lesions may worsen
the clinical presentation and prognosis [8]. The National
Kidney Foundation (NKF) defined chronic kidney dis-
ease as kidney damage for three or more months associ-
ated with structural or functional abnormalities of thel. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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rate (GFR) [9]. Furthermore, CKD is a public health
problem with a high impact on quality of life [10]. CKD
incidence is 337 per million in United States of America
and 95 per million populations in United Kingdom [11].
In Nigeria, the incidence is 1.8-10% (1,800-10,000 per
million population) and it represents 27.17% of all med-
ical outpatients’ clinic attendance. CKD is therefore
regarded as one of the major public health problems in
Nigeria [12].
CKD is associated with clinical and radiographic
changes in the mouth [6,11]. The radiographic changes in-
clude loss of lamina dura, maxillary and mandibular radio-
lucent lesions [11]. The clinical findings in CKD patients
are essentially as stated for oral lesions in systemic disease
[6]. Unfortunately, attention to the oral aspects has been
lacking despite the many merits associated 13]. High graft
rejection rate (in kidney transplant patients) [13] and in-
crease in systemic inflammatory burden which worsen the
underlying systemic disease [8] are consequences of un-
treated oral lesions in CKD.
The cause effect relationship between oral infections
and systemic diseases is yet to be fully established; how-
ever significant improvement in the underlying systemic
diseases has been reported following treatment of associ-
ated oral lesions [14]. This is a pointer to the importance
of oral health care in the management of systemic dis-
eases. In the developed countries, there are guidelines
for oral health care in patients with systemic diseases
[15]. The reverse is the case in the developing countries
where inadequate attention has been given to oral health
care needs in this group of patients and this has further
worsened the prognosis of the underlying disease [13].
Poor dental awareness among the patients and some
medical colleagues are contributory factors [16].
This study investigated oral lesions in CKD in our en-
vironment and the association with renal function impair-
ment. An oral health care protocol for the management of
CKD patients was also suggested.
Methods
Study design
The study was a case control study comparing oral le-
sions in CKD patients attending the renal clinic of the
Obafemi Awolowo University Teaching Hospitals Com-
plex, Ile Ife, Nigeria with controls from the General
Medical Outpatient Clinic between September 2011
and March 2012.
Subjects
The study group consisted of patients diagnosed with
chronic renal failure and end stage renal disease. This
group was randomly selected from the pool of CKD pa-
tients being managed by the Renal Unit of the ObafemiAwolowo University Teaching Hospital Complex, Ile-Ife,
Nigeria. Subjects selected were 18 years and above with
no co-morbid medical conditions like diabetes mellitus
and primary hypertension as well as negative history of
cigarette and alcohol consumption.
The control group comprised clinically healthy sub-
jects who visited the general out-patient department
(GOPD) of the hospital on account of pre-employment,
pre-admission and routine medical checkup. Control
subjects were recruited if they had normal estimated
glomerular filtration rate (eGFR) (GFR above 120 ml/
min per 1.73 m2 surface area). The GFR was estimated
using the Cockcroft and Gault equation [17]. Other in-
clusion criteria for control subjects were negative history
of kidney disease or other chronic debilitating illnesses,
cigarette smoking or alcohol consumption.
Ethical issues
Ethical clearance was obtained from the Ethics and Re-
search committee (ERC), Obafemi Awolowo University
Teaching Hospitals Complex, Ile-Ife.
Sample size estimation
Xerostomia, previously estimated to be 20% prevalent in
the adult population was used to estimate the sample
size [18]. With alpha set at 5%, power at 90% and preva-
lence of xerostomia projected to be 45% in renal patients
as reported by De la Rosa et al. [19], 80 subjects were re-
quired in each group.
Data collection
Patients who met the inclusion criteria were informed
about the study after which a signed consent was ob-
tained. Information on patients’ biodata, relevant medical
history, drug history, alcohol and tobacco consumption
was recorded in addition to the blood pressure and weight
of subjects.
Detailed extra oral and intraoral examination was
done, and organoleptic method was used to assess hali-
tosis. Oral mucosa assessment was based on the WHO
Guide to Epidemiology and Diagnosis of Oral Mucosal
Diseases [20].
Periodontal health assessment
Oral hygiene was assessed using Greene and Vermilion
oral hygiene index [21]. Generally, a tooth is said to have
developed periodontitis when there is an established
pocket of more than 3 mm depth [22]. For this study,
teeth with established pocket more than 3 mm were de-
scribed as positive for periodontitis. Periodontal pocket
was measured with the Magil ‘O’ periodontal probe
which has marking at 3 mm point from the tip and thus
making it easier to pick subjects with periodontics (peri-
odontitis in this study is set at a pocket of 3 mm and
Table 1 Sociodemographic factors and oral complaints
Characteristics All CKD Controls p
valuen = 180 n = 90 n = 90
Average age (SD) 47.73 (16.1) 50.39 (15.3) 45.18 (16.5)
Sex
Male 108 (60) 63 (58) 45 (42)
Female 72 (40 27 (37.5) 45 (62.5) <0.001*
Ethnicity
Yoruba 87 (96.7) 82 (91.1)
Hausa 1 (1.1) 1 (1.1)
Ibo 7 (7.8) 2 (2.2) 0.064
Oral lesions [n (%)]
Present 102 (56.7) 87 (96.7) 15 (16.7)
Absent 78 (43.3 3 (3.3) 75 (83.3) <0.001*
Burning mouth [n (%)] 16 (8.9)
Present 16 (18) 0 (0) <0.001*
Absent 74 (82) 90 (100)
Abnormal taste [n (%)] 24 (13.3)
Present 23 (26) 1 (1) <0.001*
Absent 67 (74) 89 (99)
Bleeding gums [n (%)] 22 (12)
Present 21 (23) 1 (1)
Absent 69 (77) 89 (99) <0.001*
Halitosis 12 (7)
Present 11(12) 1 (1)
Absent 79(88) 89 (99) 0.005
Xerostomia 13 (7.2)
Present 11 (2) 2(2)
Absent 79 (88) 88 (98) 0.018
Fisher’s exact, *statistically significant.
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[23].
Gingival status
Gingival status was assessed using gingival index of Loe
H (1967) [24].
Salivary measurements
Objective salivary measurements (unstimulated whole
saliva (UWS) and stimulated whole saliva (SWS) was
done using spitting method [25].
All the examination/measurements were carried out
by one author (Oral Medicine Specialist) after prior cali-
bration. The first twenty patients were examined by two
senior specialists. The inter examiner consistency was
determined with Kappa statistics. The Kappa coefficient
for this study was 0.91 which was found to be appropri-
ate [26].
Assessment of renal function
Urinalysis was done for each patient using Combic 9®
and blood creatinine was determined from which the
estimated GFR of each subject was calculated using
Cockcroft and Gault equation [17], as follows:
Estimated creatinine clearance ml=minð Þ ¼ 140‐ageð Þ X body weight
72 X Pcr mg=dlð Þ
For female subjects, the gender correlating factor was
applied [17].
Statistical analysis
Descriptive statistics, bivariate analysis such as t-test,
Fisher’s exact and chi-square statistics or their non-
parametric equivalents were used as appropriate to com-
pare the two groups. Multivariable logistic regression
was used to determine the predictors of oral lesions.
Data analysis was done using Stata 11 statistical software
(Statacorp, College Station, Texas) and statistical signifi-
cance was inferred at p < 0.05.
Results
Distribution of the subjects
One hundred and eighty subjects participated in the
study, 108 (60%) males and 72 (40%) females. Average
age of the subjects was 47.73 ± 16.08 years and major-
ities (96.7%) of the subjects were of Yoruba ethnicity
(Table 1).
Oral soft tissue lesion
Abnormal lip pigmentation was the most frequent lesion
seen in CKD subjects, seen 81 out of 90 CKD subjects
(90%). Other significant lesions seen include candidiasis,
pale mucosa, petechial hemorrhage and periodontitis
(Table 2).Glomerular filtration rate and presence of oral lesions
A positive relationship was found between the estimated
GFR and oral lesions in cases and in controls, and this
was statistically significant as shown in the Table 3.Mean GFR and oral lesions in CKD subjects
In this study, aphthous ulcers were seen in CKD sub-
jects with high mean GFR(57.6 ml/min per 1.73 m2 sur-
face area) unlike oral candidiasis which was seen in
subjects with low mean GFR( 35.5 ml/min per 1.73 m2
surface area). Other lesions seen at a significantly lower
mean GFR are: xerostomia, halitosis and abnormal lip
pigmentation seen in subjects with mean GFR of 38.6
ml/min per 1.73 m2 surface area, 39.7 ml/min per 1.73
m2 surface area and 49.7 ml/min per 1.73 m2 surface
area respectively.
Table 2 Oral soft tissue lesions
Characteristics All Cases Controls p
valuen = 180 n = 90 n = 90,50%
Abnormal lip pigmentation [n (%)]
Present 86 (48) 81 (90) 5 (6) <0.001*
Absent 9 (10) 85 (94%)
Oral Candida infection [n (%)] 15 (8.3)
Present 14 (15.5) 1 (1) <0.001*
Absent 76 (84.5) 89 (99)
Macroglossia [n (%)] 2 (1)
Present 2 (2) 0 (0)
Absent 88 (98) 90 (100) 0.497
Depapillated tongue [n (%)] 3 (1.7)
Present 3 (3.3) 1 (1)
Absent 87 (96.6) 89 (99) 0.246
Petechial haemorrhage [n (%)] 10 (5.6)
Present 10 (11.1) 0 (0) <0.001*
Absent 80 (89.9) 90 (100)
Hyperpigmented mucosa 12 (7)
Present 11 (12) 1 (1)
Absent 79 (88) 89 (99) 0.005*
Aphthous ulcers [n (%)] 2 (1.11)
Present 2 (2) 0 (0)
Absent 78 (88) 90 (100) 0.247
Pale mucosa [n (%)] 22 (12)
Present 22 (24) 0 (0)
Absent 68 (76) 90 (100) 0.004*
Hyperemic mucosa [n (%)] 13 (7.2)
Present 13 (14.4) 0 (0)
Absent 77 (85.6) 90 (100) <0.001*
Gingivitis [n (%)] 175 (97.2%)
Present 88 (97.7) 86 (95.5)
Absent 2 (2.3) 4 (3.5) 1.000
Periodontitis [n (%)] 57 (31.2)
Present 47 (52) 10 (11.1)
Absent 43 (48) 80 (88.1) <0.01*
Gingivae recession [n (%)] 39 (21.6)
Present 35 (38.9) 4 (4.4)
Absent 55 (61.1) 86 (95.6) <0.01
Fisher’s exact, *statistically significant.
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concentration in renal patients
The mean blood urea concentration in CKD patients
with oral lesions (9.4 mmol/L) was higher compared
with those without oral lesions (5.1 mmol/L) although
the difference was not statistically significant P = 0.08.
Blood urea nitrogen was highest in patients with oralcandidiasis (12.5 mm/L) followed by those with halitosis
(12.1 mmol/L), xerostomia (11.6 mmol/L), pale mucosa
(11.1 mmol/L) and periodontitis (9.4 mmol/L).
Regression analysis
Table 4 shows the association between chronic kidney
disease and development of oral lesions after adjusting
Table 3 Glomerular filtration rate and presence of oral lesions
GFR of Subjects with oral lesions (ml/min) GFR of subjects without oral lesions (ml/min) P.value
CKD subjects 49.7 ± 22.4 77.7 ± 45.3 <0.01*
Control 109.5 ± 20.6 113.5 ± 17.7 <0.01*
All subjects (Cases and control combined) 58.5 ± 30.6 112.2 ± 20.1 <0.01*
*t- test with unequal variances.
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sions was significantly higher in subjects with CKD
compared with controls (Odds ratio 153.3, 95% C.I
(40.1-584.8), p < 0.001). Age and sex did not have a sig-
nificant relationship with the likelihood of developing
oral lesion.
Discussion
Oral lesions were present in 87 of 90 subjects with
CKD, representing a prevalence of 97%. This is consist-
ent with studies from different parts of the world ex-
cluding Africa that reported up to 90% of CKD patients
showing oral symptoms in the course of their kidney
disease [11,27]. In some reports, prevalence of oral le-
sions in CKD was 100% [6]. Oral lesions are usually
due to restricted diets, malnutrition, mouth neglect,
immunosuppression and the effects of medications and
ureamic toxins on the oral tissues [11]. CKD patients
on hemodialysis have also been found to be associated
with reduced dental visits which further worsen the
oral care [28]. The high prevalence in this study may be
attributed to the peculiarity of patients’ presentation
and local factors that affect the choice of the treatment
options affordable in this part of the world. Most
Nigerians present late to health facilities and oftentimes
would have tried various forms of alternative medicine
like spiritual and traditional/native healers before pre-
senting to a health facility [12,29]. This late presenta-
tion is due to ignorance and poor accessibility and
affordability of health care services [30]. Majority of pa-
tients, therefore, present at late stages when oral lesions
were more likely prevalent. Oral lesions were more
prevalent in males (64%) and this is consistent with
other reports who attributed this to the predilection of
CKD for males [11]. Oral lesions (pathologic conditions
in the mouth), oral signs (abnormalities of oral mucosa
found on clinical oral examinations) and oral complaintsTable 4 Role of chronic kidney disease on development
of oral lesions
Covariate Odds ratio Standard error 95% CI p value
CKD 153.5 104.3 40.5-581.4 <0.001*
Age 1.03 0.17 1.0-1.06 0.45
Sex (Male) 0.93 0.33-2.6 0.33-2.63 0.89
*Statistically significant, Hosmer-Lemeshow goodness of fit test p = 0.1914.(described by patients) are the various terms used in
describing the oral aspects of kidney disease in the lit-
erature [31].
Abnormal lip pigmentation, the most prevalent oral le-
sion observed in our CKD patients was not commonly
reported among renal patients in the earlier studies
[11,27]. Oral and cutaneous hyperpigmentation in renal
patients is due to inability of the kidney to excrete excess
beta melanocyte stimulating hormone (b-MSH), the ac-
cumulation of which results in the stimulation of mel-
anocyte at the basal layer of oral epithelium [32]. The
possible reasons for the high frequency of hyperpigmen-
tation in our environment may be due to the abuse of
traditional or orthodox drugs for the treatment of kidney
disease or other diseases. These drugs which include anti-
malarials (quinacrine, chloroquine, hydroxychloroquine)
may stimulate melanin secretion and are easily accessible
in our environment [33]. In addition, these drugs which
are also known to induce hypermelanosis are frequently
used by these patients before presentation. Genetic factors
(black race) and hot climate associated with constant ex-
posure of the melanocytes to sunlight may also hasten
hyperpigmentation. Consequently, abnormal lip and face
pigmentation constitutes a great aesthetic challenge to
renal patients [34].
Abnormal taste has been commonly reported and
was present in 23 (26%) of the CKD subjects [11,35].
The mechanisms underlying alterations in taste percep-
tion in uremia patients are unknown, but are probably
attributable to influences of ureamic toxins on the cen-
tral nervous system (CNS) and the peripheral nervous
system (the taste receptors) [36]. Bleeding gum was
seen in 23 out of 90 (26%) CKD subjects and has been
attributed to poor oral hygiene, ginigival/periodontal
inflammation and bleeding abnormalities [37]. Simi-
larly, burning mouth sensation which was significantly
higher in CKD patients (16%) was a consistent finding
in many other studies. It was attributed to effects of dry
mouth, damage to peripheral nerves by the ureamic
toxins and effects of medication [11,38].
In CKD, there is usually fluid restriction, electrolyte
imbalance, and use of medications, such as frusemide
and hydrochlorothiazide. These may contribute to the
complaint of a dry mouth seen in 12.22% of the renal
patients in our study. Other researchers documented a
much higher prevalence of 48.2% [39] and 32.9% [40].
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Saharan Africa may be due to the primary aetiology of
kidney disease in these regions. The aetiological factors in
these regions such as diabetes mellitus, hypertension,
amyloidosis and autoimmune disease not only cause renal
disease but also initiate salivary gland disease independ-
ently [12]. In Africans, the commonest aetiology of renal
disease is glomerulonephritis which usually results from
infections [29]. The complaint of halitosis was signifi-
cantly higher in CKD patients (12%) and has been at-
tributed to dry mouth, poor oral hygiene and ureamic
smell [11].
The lower mean stimulated and unstimulated salivary
production found in CKD patients (2.34 ml/5 min and
4.07 ml/5 min) when compared to the controls (3.82 ml/
5 min and 8.05 ml/5 min) was consistent with majority
of earlier studies [11,41,42]. This finding is similar to
that of Kho and colleagues [40] who reported 0.44 +
0.29 ml/min and 1.5 + 0.5 ml/min for unstipulated
whole salivary (UWS) flow rate in renal patients and
controls respectively. Reduced salivary flow rate is a con-
sistent finding in CKD patients and it has been reported
that reduce flow is due to effects of drugs, emotional
stress and neuropathy in CKD patients [43].
Oral candidiasis was more prevalent in CKD cases and
may be due to immune suppression from malnutrition,
restricted diets, anaemia, stress, and immunosuppressive
drugs. Result of this study was consistent with the find-
ings of Al-Mohaya [44] and colleagues who reported
15.5%, and De la Rosa-Garcia [45] (18.8%). However
these studies were carried out among post-renal trans-
plant chronic kidney disease patients. Considering aFigure 1 Mean GFR and oral lesions in CKD subjects.higher prevalence of oral candidiasis (37%) reported by
Royne and colleagues [46] and lower prevalence of 5.7%
reported by Gavalda and co-workers [47], oral candidia-
sis appears to be a consistent finding in patients with
chronic kidney disease [11,27]. Late presentation of pa-
tients, environmental factors and possibly genetic varia-
tions may account for the little variation between our
study and the above mentioned studies.
Gingival swelling, described by Proctor and colleagues
[11] and Al-Mohaya and co-workers [44] as the common-
est oral manifestation of renal disease was not observed in
this study despite the prevalent poor oral hygiene. Gum
swellings arise from use of medications such as nifedipine,
cyclosporine and tacrolimus [6,11,44]. These drugs are not
routinely used in the management of renal cases in our
hospital. The drugs used in our hospital are lisinopril and
amlodipine for the treatment of hypertension in renal pa-
tients with other supportive drugs. These drugs (lisinopril
and amlodipine), unlike nifedipine and cyclosporine,
are not associated with gum swellings. Furthermore,
most of our patients cannot afford the cost of renal
transplantation, a peculiar problem in this environment
and developing nations [29]. Such patients (which consti-
tute the majority) are placed on palliative management
consisting of the pharmacodietary approach, without the
need for immune suppressant drugs that may predispose
to gingival swelling.
Glomerular filtration rate and oral findings
Majority of the studies reported a GFR range of 90-120
ml/1.73 m2 surface area as normal for an adult, with
lower values indicating poor renal function [6,17,37]. It
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lesions was significantly lower than mean GFR of those
without oral lesion p < 0.001, showing a strong relation-
ship between presence of oral lesions and reduction in
GFR especially in CKD subjects. Systemic inflammation
arising from oral infection could have an effect on mi-
crovasculature of heart and kidney [4,6]. The possible
establishment of bi-directional relationship between oral
infection such as between periodontitis and heart disease
has also been postulated between oral lesion and kidney
disease [6,8]. This probably explains the lower mean
GFR in CKD subjects with oral lesions when compared
with a relatively higher mean GFR in CKD subjects with-
out oral lesions.
Conclusion
The prevalence of oral lesions was higher in CKD sub-
jects than in controls and the difference was statistically
significant. Abnormal lip pigmentation, halitosis, peri-
odontitis and candidiasis are some of the oral lesions
seen. The presence of oral lesions was also associated
with reduced GFR in both CKD and control subjects.
The positive association between the presence of oral le-
sions and reduced GFR in healthy/control subjects is a
pointer to the possible role(s) of oral lesions in the initi-
ation and/or progression of renal disease.
In addition, this study showed the possibility of using
presence of oral lesions to predict the severity of under-
lying renal problem as shown in Figure 1 where the rela-
tionship between the mean GFR and oral lesions were
clearly shown. While the presence of oral candidiasis
(seen in subjects very low GFR) may indicate a state of
severe renal impairments, the presence of lesions like
aphthous ulcer may reflect a just mild to moderate renal
disease since they are usually seen at slightly below nor-
mal GFR.
Sequel to the impact of oral aspect of CKD in the
quality of life of patients, it is therefore recommended
that all patients with chronic kidney disease will benefit
from dental care; therefore, they should be routinely
evaluated for oral lesion(s) and treated accordingly. Like-
wise, dental evaluation and appropriate dental treatments
should be given to all prospective kidney transplant pa-
tients before transplantation as well as regular review after
the transplantation. More importantly, there is need for a
closer relationship between nephrologists and dentists in
the management of chronic renal patients so as to ensure
optimal quality of life at all times.
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